Refinement of prespecified cutoff for genomic loss of heterozygosity (LOH) in ARIEL2 part 1: A phase II study of rucaparib in patients (pts) with high grade ovarian carcinoma (HGOC) Meeting Abstract
| Authors: | Coleman, R. L.; Swisher, E. M.; Oza, A. M.; Scott, C. L.; Giordano, H.; Lin, K. K.; Konecny, G. E.; Tinker, A.; O'Malley, D. M.; Kristeleit, R. S.; Ma, L.; Bell-McGuinn, K. M.; Brenton, J. D.; Cragun, J. M.; Oaknin, A.; Ray-Coquard, I. L.; Kaufmann, S. H.; Goble, S.; Maloney, L.; McNeish, I. A. |
| Abstract Title: | Refinement of prespecified cutoff for genomic loss of heterozygosity (LOH) in ARIEL2 part 1: A phase II study of rucaparib in patients (pts) with high grade ovarian carcinoma (HGOC) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 299s |
| Language: | English |
| ACCESSION: | WOS:000404711501213 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.5540 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5540 -- Source: Wos |
